Home›Companies›Healthcare›Teal Bio

Teal Bio, Inc.

Updated Oct 27, 2026·Latest SEC filing Dec 27, 2023·Suggest an edit

About Teal Bio

Teal Bio is a private company based in Somerville, Massachusetts, incorporated in 2020 in Delaware. It has reported $3,793,634 raised in three offerings on Form D since February 2021. Its chief executive is Michael Singer.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Nov 16, 2023Dec 27, 2023$218,634of $950K target4$54,659Equity, Options, Securities on exerciseRule 506(b)Form D ↗
Nov 9, 2021Nov 23, 2021amended Feb 6, 2023$3,000,000fully sold15$200KEquityRule 506(b)Form D/A ↗1 earlier filing
Dec 2, 2020Feb 5, 2021$575,000fully sold2$287KDebt, OptionsRule 506(b)Form D ↗
Total, three offerings$3,793,634

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Teal Bio's Form D filed Dec 27, 2023.

CT
MS
Michael Singer
Chief Executive Officer
Robert Langer
Robert Langer
Director
Also a director at SunBird Bio and Syntis Bio and a co-founder & scientific advisor, director at SUTOL Bio.
JT
Jason Troutner
Executive officer

Earlier filings also listed Tony Casciano (chief executive officer and director, last listed Feb 2023).

Sources

  1. SECTeal Bio, Inc. Form D, filed Nov 23, 2021
  2. SECTeal Bio, Inc. filing history